DK0946567T3 - New Camptothecin Analog Compounds, Their Use as Drugs and Pharmaceuticals Containing Them - Google Patents

New Camptothecin Analog Compounds, Their Use as Drugs and Pharmaceuticals Containing Them

Info

Publication number
DK0946567T3
DK0946567T3 DK97950236T DK97950236T DK0946567T3 DK 0946567 T3 DK0946567 T3 DK 0946567T3 DK 97950236 T DK97950236 T DK 97950236T DK 97950236 T DK97950236 T DK 97950236T DK 0946567 T3 DK0946567 T3 DK 0946567T3
Authority
DK
Denmark
Prior art keywords
drugs
analog compounds
pharmaceuticals containing
camptothecin analog
new camptothecin
Prior art date
Application number
DK97950236T
Other languages
Danish (da)
Inventor
Dennis Bigg
Olivier Lavergne
Rodas Francesc Pla
Jacques Pommier
Gerard Ulibarri
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK0946567T3 publication Critical patent/DK0946567T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
DK97950236T 1996-12-20 1997-12-05 New Camptothecin Analog Compounds, Their Use as Drugs and Pharmaceuticals Containing Them DK0946567T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615774A FR2757514B1 (en) 1996-12-20 1996-12-20 NOVEL CAMPTOTHECIN ANALOGS, PREPARATION METHODS, USE THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR1997/002218 WO1998028305A1 (en) 1996-12-20 1997-12-05 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DK0946567T3 true DK0946567T3 (en) 2003-12-22

Family

ID=9498938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97950236T DK0946567T3 (en) 1996-12-20 1997-12-05 New Camptothecin Analog Compounds, Their Use as Drugs and Pharmaceuticals Containing Them

Country Status (26)

Country Link
EP (1) EP0946567B1 (en)
JP (2) JP3576175B2 (en)
KR (1) KR100516874B1 (en)
CN (1) CN1097056C (en)
AR (1) AR008543A1 (en)
AT (1) ATE248177T1 (en)
AU (1) AU734485B2 (en)
BR (1) BR9714170A (en)
CA (1) CA2275351C (en)
CZ (1) CZ299795B6 (en)
DE (1) DE69724453T2 (en)
DK (1) DK0946567T3 (en)
ES (1) ES2206761T3 (en)
FR (1) FR2757514B1 (en)
HK (1) HK1024695A1 (en)
HU (1) HUP9904210A3 (en)
MX (1) MXPA99005776A (en)
MY (1) MY119473A (en)
NO (1) NO326464B1 (en)
NZ (1) NZ335939A (en)
PL (1) PL188181B1 (en)
PT (1) PT946567E (en)
RU (1) RU2194051C2 (en)
UA (1) UA57758C2 (en)
WO (1) WO1998028305A1 (en)
ZA (1) ZA9711129B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790261B1 (en) * 1999-02-26 2004-09-10 Sod Conseils Rech Applic NOVEL OPTICALLY PURE CAMPTOTHECIN ANALOGS AND PROCESSES FOR THEIR PREPARATION
US6291676B1 (en) * 1999-03-03 2001-09-18 University Of Kentucky Research Foundation Water-soluble derivatives of camptothecin/homocamptothecin
US6207832B1 (en) * 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
AU3455100A (en) * 1999-05-28 2000-12-18 Nippon Chemiphar Co. Ltd. Process for the preparation of 2-halo-3-(3-quinolyl)propionic acid derivatives
US6372906B1 (en) 2001-04-12 2002-04-16 University Of Pittsburgh Synthesis of silyl camptothecins and silyl homocamptothecins
US6723853B2 (en) 2001-08-27 2004-04-20 University Of Pittsburgh Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins
AU2003225642A1 (en) * 2002-03-01 2003-09-16 Fluorous Techonologies Inc Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
ITRM20040288A1 (en) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti USE OF 7-T-BUTOXYIMINOMETHYL CAMPTOTECIN FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF UTERUS NEOPLASIES.
CA2580747A1 (en) * 2004-09-21 2006-03-30 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R .A.S.) Novel processes for the production of useful intermediates
CN102746314B (en) * 2011-04-18 2016-07-06 华东师范大学 Containing stablizing the camptothecine compounds of 7 yuan of lactonic rings, preparation method and purposes
WO2023232145A1 (en) * 2022-06-02 2023-12-07 华东师范大学 Small molecule of homocamptothecins and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391745A (en) * 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
DK0835258T3 (en) * 1995-06-21 2003-02-03 Sod Conseils Rech Applic New Camptothecin Analogs, Methods of Preparation thereof, Their Use as Medicines and Pharmaceutical Preparations Containing These

Also Published As

Publication number Publication date
AR008543A1 (en) 2000-01-19
EP0946567A1 (en) 1999-10-06
MXPA99005776A (en) 2004-08-31
EP0946567B1 (en) 2003-08-27
JP2004115535A (en) 2004-04-15
UA57758C2 (en) 2003-07-15
CA2275351C (en) 2008-10-14
JP2001505922A (en) 2001-05-08
ZA9711129B (en) 1999-05-03
WO1998028305A1 (en) 1998-07-02
KR100516874B1 (en) 2005-09-26
AU5326598A (en) 1998-07-17
NO992998L (en) 1999-08-18
ATE248177T1 (en) 2003-09-15
FR2757514B1 (en) 1999-02-12
KR20000069608A (en) 2000-11-25
PL334125A1 (en) 2000-02-14
DE69724453T2 (en) 2004-06-09
NO326464B1 (en) 2008-12-08
HK1024695A1 (en) 2000-10-20
NZ335939A (en) 2000-04-28
JP3576175B2 (en) 2004-10-13
PL188181B1 (en) 2004-12-31
CA2275351A1 (en) 1998-07-02
HUP9904210A2 (en) 2000-05-28
CZ220599A3 (en) 1999-09-15
FR2757514A1 (en) 1998-06-26
BR9714170A (en) 2000-02-29
NO992998D0 (en) 1999-06-18
AU734485B2 (en) 2001-06-14
ES2206761T3 (en) 2004-05-16
CZ299795B6 (en) 2008-11-26
MY119473A (en) 2005-05-31
DE69724453D1 (en) 2003-10-02
RU2194051C2 (en) 2002-12-10
PT946567E (en) 2004-01-30
CN1241191A (en) 2000-01-12
CN1097056C (en) 2002-12-25
HUP9904210A3 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
DK0835246T3 (en) Aromatic compounds and pharmaceutical preparations containing them
NO308298B1 (en) Substituted quinazoline derivatives, their use and pharmaceutical preparations containing them
DK0966454T3 (en) Disubstituted bicyclic heterocycles, their preparation and their use as drugs
NO20002113L (en) Novel tricyclic compounds and their use in medicine, processes for their preparation and pharmaceutical compositions containing them
NO942835L (en) 1-Benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
NO991815L (en) Oxadiazoles, processes for their preparation and their use as drugs
NO942834L (en) 1-Benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, preparation thereof, and pharmaceutical compositions containing them
NO20001409L (en) Carboxamidothiazole derivatives, processes for their preparation and pharmaceutical compositions
NO20014013D0 (en) 16-halogenepotilone derivatives, processes for their preparation and their pharmaceutical use
DK1538160T3 (en) Substituted isoquinoline-3-carboxylic acid amides, their preparation and their use as a drug
DK1112266T3 (en) Substituted 4-amino-2-arylpyrimidines, their preparation and use, and pharmaceutical compositions containing them
DK1095020T3 (en) 2-Aminopyridine derivatives, their use as pharmaceuticals and pharmaceutical compositions containing them
IS5353A (en) Acyl-piperazinil-pyrimidine derivatives, their preparation and use as pharmaceuticals
DK1222163T3 (en) 2'-Substituted 1,1'-biphenyl-2-carboxamides, methods of preparation thereof, their use as a medicament, and pharmaceutical compositions containing them
DK0912613T3 (en) Synthetic polysaccharides, processes for their preparation and pharmaceutical compositions containing them
DK0732328T3 (en) Heterocyclic, aromatic compounds, pharmaceutical and cosmetic compositions containing them, and uses
NO923509L (en) N-SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARING THEREOF AND PHARMACEUTICAL MIXTURES CONTAINING THEM
DK0946567T3 (en) New Camptothecin Analog Compounds, Their Use as Drugs and Pharmaceuticals Containing Them
NO983472D0 (en) Taxoids, their preparation and pharmaceutical preparations containing the taxoids
DK1210348T3 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them
DK0986537T3 (en) Heteroethynylene Compounds and Pharmaceuticals and Cosmetic Compositions Containing Them
DK1149832T3 (en) Benzamide derivatives and drugs containing them
HUP9802590A3 (en) Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
NO20002114D0 (en) Bicyclic compounds, processes for their preparation, and pharmaceutical compositions containing them
NO20002483L (en) New 19-norsteroids substituted in heading 11B, manufacturing methods and intermediates, use as medicines and pharmaceutical preparations containing them